Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer
Tharimmune (NASDAQ: THAR) announced leadership changes effective Feb 5, 2026: Mark Wendland was elected Chairman of the Board and Angela Radkowski was named Chief Operating Officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tharimmune (NASDAQ: THAR) announced leadership changes effective Feb 5, 2026: Mark Wendland was elected Chairman of the Board and Angela Radkowski was named Chief Operating Officer. Vincent LoPriore will transition from Chairman to a Board member. Radkowski joins from DRW and Citadel and will lead operations, the Canton Network quarterly research initiative, and Super Validator activation. Tharimmune reaffirmed its Canton Network-aligned digital asset treasury strategy established in November 2025, plans CC acquisition, Super Validator operations, and investments in Canton-based applications. Tharimmune is the first publicly traded company supported by the Canton Foundation.
Positive
- Mark Wendland elected Chairman effective Feb 5, 2026
- Angela Radkowski appointed COO to lead operations and Super Validator activation
- Company established a digital asset treasury strategy in November 2025
- Firm intends to acquire Canton Coin (CC) and operate as a Super Validator
- First publicly traded company supported by the Canton Foundation
Negative
- None.
Details
News Market Reaction – THAR
On Feb 6, the day this news came out, THAR closed 5.34% above the previous close.
Data tracked by StockTitan Argus for the Feb 6 session.
Key Figures
- Shelf registration
- $2,000,000,000
- Maximum aggregate amount under S-3 shelf filed January 9, 2026
- PIPE transaction
- $545 million
- Recent PIPE deal partly funded with Canton Coin
- ATM capacity
- $64,910,161
- Maximum common stock that can be sold via ATM program
- Shares outstanding
- 37,386,114
- Common shares outstanding as of January 6, 2026 (shelf filing)
- LCV warrants
- 16,500,504 warrants
- Warrants exercisable at $0.0001 per share, subject to 9.99% blocker
- Equity plan increase
- 7,000,000 shares
- Additional shares for 2023 Omnibus Equity Incentive Plan approved Jan 30, 2026
- Registered offering size
- $55 million
- Underwritten registered offering announced January 20–22, 2026
- ARK ownership
- 3,252,033 shares (8.92%)
- Beneficial ownership reported on Schedule 13G as of 12/31/2025
Historical Context
-
Strong revenue, net income, dividend increase and buyback authorization at TW.
-
Election of two directors with regulatory and capital-markets expertise.
-
Approval to operate as a Super Validator on the Canton Network.
-
Closing of a $55M underwritten registered direct offering to fund Canton strategy.
-
Pricing of $55M underwritten registered offering for growth capital.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
digital asset financial
blockchain technical
treasury strategy financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy
Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion
In her role as COO, Ms. Radkowski will oversee operational control functions and enterprise processes, including the implementation of Tharimmune's Canton Network quarterly research initiative and Super Validator activation.
"I am honored to assume the role of Chairman as we continue executing on our Canton Network-aligned digital asset strategy to help modernize financial market infrastructure," said Mark Wendland. "The Board, under the dedicated leadership of Vincent LoPriore, has demonstrated an unwavering commitment to building a governance and operating structure capable of supporting our digital asset treasury strategy, and Angela's appointment adds critical leadership at a pivotal moment. Her experience scaling complex financial systems will be instrumental as we advance institutional adoption of Canton Network and drive value for shareholders."
Prior to her appointment, Ms. Radkowski served as Operations Strategy Lead and Chief of Staff to the Chief Operating Officer at DRW Holdings LLC, advising senior leadership, coordinating cross-functional communication, and managing high-priority, enterprise-level initiatives. Ms. Radkowski previously held positions within Citadel LLC's Treasury and Engineering organizations, where she was responsible for coordinating enterprise deliverables involving optimization, data engineering, and technology upgrades.
Ms. Radkowski added, "The Canton Network introduces a new model for institutional finance — one that addresses the limitations of legacy infrastructure while enabling secure, scalable blockchain adoption. I am excited to join Tharimmune and help build the operational foundation required to support this transformation."
Tharimmune established its differentiated digital asset treasury strategy in November 2025. In addition to driving value through CC acquisition and operating as a Super Validator, Tharimmune intends to invest in applications built on the Canton Network that accelerate institutional utility and adoption across capital markets. Tharimmune is the first and only publicly traded company supported by the Canton Foundation.
About Tharimmune
Tharimmune, Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development. For more information, visit: www.tharimmune.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements" within the meaning of
Contacts
Media:
Gasthalter & Co.
(212) 257-4170
canton@gasthalter.com
Investors:
ir@tharimmune.com
X: @TharimmuneInc
LinkedIn: https://www.linkedin.com/company/tharimmune-inc/
Website: https://tharimmune.com/
View original content:https://www.prnewswire.com/news-releases/tharimmune-inc-appoints-mark-wendland-chairman-of-the-board-and-names-angela-radkowski-chief-operating-officer-302681307.html
SOURCE Tharimmune, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.